NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Single and Repeated Doses of SAR441344 in Healthy Adult Subjects

NCT05845996

CompletedPhase 1

Sponsor: Sanofi

Conditions: Healthy Volunteers

Interventions: SAR441344, placebo, Keyhole limpet hemocyanin

Countries: United States

Primary Objective is the tolerability and safety of ascending single and repeated intravenous infusion (IV) and/or subcutaneous (SC) administration of SAR441344

Eligibility overview

Sex: ALL

Age: 18 Years to 45 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion criteria

\- Having given written informed consent prior to undertaking any study-related procedure.

Exclusion criteria

\- Any subject who, in the judgment of the Investigator, is likely to be noncompliant during the study, or unable to cooperate because of a language problem or poor mental development.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Locations (1)

Austin, Texas, United States